
Hepion (HEPA) Stock Is Surging Before A Trial Data Review
Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) is experiencing a notable uptrend today, marking a 14.95% surge during the morning session, with its stock value reaching $3.3450.
Home » Hepion Pharmaceuticals
Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) is experiencing a notable uptrend today, marking a 14.95% surge during the morning session, with its stock value reaching $3.3450.
Biotech and Major Pharmaceuticals are back in the news with the Covid-19 Pandemic. Life science investors basically endorse developments that might decide the human race’s
On December 8, American stock exchanges closed at historic highs. The S&P 500 Index climbed 0.28% to 3702 points, the Dow Jones added 0.35%, the
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.